Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Throm
about
sameAs
Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study.Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial.Evaluation of the consequences associated with diffuse vascular disease history in patients diagnosed with peripheral arterial disease: estimates from Saskatchewan health datan-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial.Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease.Ankle/brachial index to everyoneClinical correlates of red blood cell omega-3 fatty acid content in male veterans with peripheral arterial disease.Advancing beyond the "heart-healthy diet" for peripheral arterial diseaseCoronary angiography in patients undergoing carotid artery stenting shows a high incidence of significant coronary artery disease.Peripheral arterial disease in patients presenting with acute coronary syndrome in six middle eastern countries.Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial)Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction.Effect of prior stroke on the use of evidence-based therapies and in-hospital outcomes in patients with myocardial infarction (from the NCDR ACTION GWTG registry).Peripheral arterial disease in the Middle East: Underestimated predictor of worse outcome.Risk stratification and timing of revascularization: which patients benefit from early versus later revascularization?Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA).Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes.Causes of Death in Patients with Severe Aortic Stenosis: An Observational study.The impact of polyvascular disease on long-term outcome in percutaneous coronary intervention patients.Outcomes and risk prediction model for peripheral arterial disease in patients with stable coronary artery disease.Ankle-brachial index and coronary artery lesion complexity in patients with acute coronary syndromes.Interactions between cardiovascular and cerebrovascular diseasePolyvascular disease in patients presenting with acute coronary syndrome: its predictors and outcomes
P2860
Q30595680-99AAFC29-D768-438F-8595-BC319BEB0783Q30821177-BE0624FE-915E-4FF5-B3CC-C9D956481A1AQ33682860-7E57368B-9A6D-4421-BA14-D85BFE063402Q33819705-69B542FC-AC2C-49D0-88D2-7E2CD9899E92Q34391653-8FF615E7-102A-4F52-B60E-085125A467C2Q34486105-AE87398A-4369-40C7-8FCC-ACD41D0A50D5Q34621812-7920D7D3-A965-4E57-B736-4B5DB2043145Q34767372-47783EA8-E840-4BC4-B6D0-EADD8ADE155CQ35584968-03997AA3-C38E-453C-BD50-B3BCDC9AA215Q35636249-D1F15535-E1AD-4570-BEC3-DCBCD0FA8268Q36141602-E4D2B92C-05C2-46B4-9A0E-FF6E644FF878Q36999542-18B2EC39-206F-4E3B-A3A3-2DFFC9FA3FABQ37095212-E44E2C5E-C658-43EE-AEB6-4AD13C147836Q37659222-FD1AACDE-A060-470F-AE4D-01F61B4716ADQ38009702-571AB377-E5BA-4967-819F-0C0E9DC00BBEQ43054647-E824547A-A51C-458A-ABFE-1D53C0A899A9Q44445340-2AF55FDC-9233-464E-8F55-587459991431Q44564513-52571EDC-0451-46CF-8FBC-C74436C0EEAAQ46429800-4B6E45AF-C96E-49AF-8E00-CE3F108C6AB7Q51019211-359385B0-4AAC-4F63-A9AD-E117E2076067Q51452557-2F9BEFB6-A5FE-4B20-9B3B-5506F38878D2Q56979792-CDFC637D-E1BF-4F88-B241-280EAF58D3F6Q58914722-98E8FE2E-0D3A-488E-BFD4-2EE6093D8863
P2860
Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Throm
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Prior peripheral arterial dise ...... table Coronary Syndromes-Throm
@nl
type
label
Prior peripheral arterial dise ...... table Coronary Syndromes-Throm
@nl
prefLabel
Prior peripheral arterial dise ...... table Coronary Syndromes-Throm
@nl
P2093
P50
P356
P1476
Prior peripheral arterial dise ...... nfarction (OPUS-TIMI) 16 study
@en
P2093
Alex Blatt
Alon Marmor
Andrew Charlesworth
Basil Lewis
Carolyn H McCabe
Christopher P Cannon
Jane Bentley
Leonardo Reisin
P356
10.1067/MHJ.2003.6
P407
P577
2003-04-01T00:00:00Z